CC(=O)Nc1ccc(-c2ccnc3c2CC(C)(C(=O)NCc2cccc(Cl)c2)O3)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?